NCT05084599View on ClinicalTrials.gov

Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

May 12, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Cesarean Section Complications
Interventions
DRUG

Metaraminol 2.7μg/kg/min

After spinal anesthesia, the patient was placed in a supine position until the fetus was delivered, and metaraminol was given at an initial rate of 2.7μg/kg/min throughout the process.

DRUG

Metaraminol 2μg/kg/min

After spinal anesthesia, the patient was placed in left-tilt position until the fetus was delivered, and metaraminol was given at an initial rate of 2μg/kg/min throughout the process.

Trial Locations (1)

100044

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER